Continuous ethylene tetramerization process
US-2015284303-A1 · Oct 8, 2015 · US
US10207262B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10207262-B2 |
| Application number | US-201615557886-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 10, 2016 |
| Priority date | Mar 13, 2015 |
| Publication date | Feb 19, 2019 |
| Grant date | Feb 19, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to oligomerization of olefins, such as ethylene, to higher olefins, such as a mixture of 1-hexene and 1-octene, using a catalyst system that comprises a) a source of chromium b) one or more activators and c) a phosphacycle-containing ligating compound. Additionally, the invention relates to a phosphacycle-containing ligating compound and a process for making said compound.
Opening claim text (preview).
What is claimed is: 1. A catalyst system comprising a) a source of chromium selected from the group consisting of CrCl 3 (THF) 3 (trichlorotris(tetrahydrofuran)chromium), CrBr 3 (THF) 3 , CrI 3 (THF) 3 , CrCl 3 , CrBr 3 , CrI 3 , CrCl 2 , CrCl 2 (THF) 2 , Cr(acac) 3 (chromium (III) acetylacetonate), Cr(acetate) 3 (chromium (III) acetate), Cr(2-ethylhexanoate) 3 (chromium (III) 2-ethylhexanoate), (THF) 3 CrMeCl 2 , (Mes) 3 Cr(THF), ((TFA) 2 Cr(OEt) 2 ) 2 , (THF) 3 CrPh 3 , Cr(NMe 3 ) 2 Cl 3 , Cr(neopentyl) 3 (THF) 3 , Cr(CH 2 —C 6 H 4 -o-NMe 2 ) 3 , Cr(TFA) 3 , Cr(CH(SiMe 3 ) 2 ) 3 , Cr(Mes) 2 (THF) 3 , Cr(Mes) 2 (THF)Cr(Mes) 2 (THF) 2 , Cr(Mes)Cl(THF) 2 , Cr(Mes)Cl(THF) 0.5 , Cr(p-tolyl)Cl 2 (THF) 3 , Cr(diisopropylamide) 3 , Cr(picolinate) 3 , Cr(NO 3 ) 3 , Cr(hexafluoroacetylacetonato) 3 , (THF) 3 Cr(η 2 -2,2″biphenyl)Br, Cr(CO) 6 , Cr(CO) 3 (THF) 3 , Cr(CO) 3 (NCCH 3 ) 3 , (benzene)Cr(CO) 3 , (toluene)Cr(CO) 3 chromium (III) acetylacetonate, chromium (III) acetate and mixtures thereof; b) one or more activators selected from the group consisting of neutral Lewis acids, Group 13 metal and metalloid compounds; polymeric alumozanes; oligomeric alumoxanes; aluminates; and, c) at least one phosphacycle-containing ligating compound of the formula: wherein: R 5 attached to N is independently C 1-40 substituted or unsubstitued alkyl, C 1-40 substituted or unsubstituted aryl; each R 5 attached to the phenyl group is independently halogen, C 1-40 substituted or unsubstituted alkyl, C 1-40 substituted or unsubstituted aryl; n is an integer from 0 to 5; and each X″ is independently hydrogen, halogen, C 1-4 aldyl or substituted alkyl, C 6-10 aryl or substituted aryl, cyano or nitro. 2. The catalyst system as in claim 1 comprising a phosphacycle-containing ligating compound-chromium complex. 3. The catalyst system of claim 1 comprising an isolated phosphacycle-containing ligating compound-chromium complex. 4. The catalyst system of claim 1 comprising an in situ-formed phosphacycle-containing ligating compound-chromium complex. 5. The catalyst system of claim 1 , wherein the source of chromium is selected from the group consisting of trichlorotris(tetrahydrofuran)chromium, chromium (III) acetylacetonate, chromium (III) 2-ethylhexanoate, and chromium (III) acetate. 6. The catalyst system of claim 1 , wherein the source of chromium and the ligating compound are contacted in proportions to provide Cr:ligating compound ratios from 1000:1 to 1:1000. 7. The catalyst system of claim 1 , wherein at least one activator is selected from the group consisting of (hydrocarbyl) aluminum compounds, (hydrocarbyl)gallium compounds, (hydrocarbyl)boron compounds, (hydrocarbyl)zinc compounds, Bronsted acid salts, salts of a cationic oxidizing agent and a non-coordinating, compatible anion, carbenium salts, and silylium salt. 8. The catalyst system of claim 1 , wherein the activator is an alkylaluminoxane. 9. The catalyst system of claim 1 , wherein the source of chromium and the aluminoxane are combined in proportions to provide chromium:activator molar ratios from 1:1 to 1:10,000. 10. The catalyst system of claims 1 - 9 wherein the phosphacycle-containing ligating compound is selected from the group consisting of:
as phosphines, arsines, stilbines or bismuthines · CPC title
Chromium · CPC title
the phosphorus atom being part of a six-membered ring which may be condensed with another ring system · CPC title
Cyclic amide derivatives of acids of phosphorus, in which two nitrogen atoms belong to the ring · CPC title
Amide derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.